Should deaths of neonates in trial have been more openly reported?
D000740:Anemia; D016265:Conflict of Interest; D004274:DNA, Recombinant; D003643:Death; D008192:Deception; D030881:Disclosure; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D035081:Editorial Policies; D004921:Erythropoietin; D017041:Ethics Committees; D028744:Ethics Committees, Research; D005378:Financial Support; D006728:Hormones; D006805:Human Experimentation; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D033181:Information Dissemination; D007255:Information Services; D009026:Mortality; D010380:Peer Review; D010919:Placebos; D028743:Professional Misconduct; D011643:Publishing; D012107:Research Design; D012108:Research Personnel; D012306:Risk; D018570:Risk Assessment; D006113:United Kingdom
Archives of Disease in Childhood; Biomedical and Behavioral Research; Cilag Ltd.; Committee on Safety of Medicines (Great Britain); St. Thomas's Hospital (London)